“…Finally, further development of the model may ultimately provide a unique opportunity to develop a hookworm vaccine in a system where vaccine safety, delivery, and efficacy can be assessed against worm establishment, parasite patency, infection-associated pathology, and cognitive development. 32,33 Furthermore, the comparatively close evolutionary relationships between marmosets and humans, the strong degree of similarity between their MHC and T cell receptor genes, their immunologic characterization, and the availability of defined reagents combined with their suitability for cognitive studies, and their acceptance by the Food and Drug Administration as being important to preclinical evaluation of biotechnology derived pharmaceuticals, 34 lend support to the choice of this species as a model for hookworm vaccination development, in preference to the less suitable mouse, hamster, and canine models.…”